Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01607905 |
| Title | Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced or Metastatic Solid Tumor Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Karyopharm Therapeutics, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | DNK | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Gabrail Cancer Center | Canton | Ohio | 44718 | United States | Details | |
| Princess Margaret Hospital | Toronto | Ontario | M5T 2M9 | Canada | Details | |
| Rigshospitalet | Copenhagen | 2100 | Denmark | Details |